Commentary|Articles|August 9, 2023
Importance of DCTs Moving Forward
Perceived barriers of DCTs can be quickly overcome to ensure their viability in clinical research.
Advertisement
In this interview from DIA 2023, Janice Chang, CEO of TransCelerate BioPharma, discusses the unique opportuntities presented by decentralized clinical trials (DCTs).
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Evolution of Preclinical CRO Strategic Partnerships: From Transactional Services to Value-Driven Ecosystems in 2026
2
What the Epilepsy Community Has Taught Us About Trial Feasibility
3
The Execution Gap: Why Clinical Trial Infrastructure Has to Be Built Before AI Can Deliver
4
ACT Brief: Endpoint Selection and Patient Engagement, Execution Infrastructure Before AI, and Real-World Data Quality Gaps
5